World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000023609
Date of registration: 12/08/2016
Prospective Registration: Yes
Primary sponsor: Kochi Medical School
Public title: Pharmacokinetic and Metabolic Analysis of Maoto
Scientific title: Pharmacokinetic and Metabolic Analysis of Maoto - Pharmacokinetic and Metabolic Analysis of Maoto
Date of first enrolment: 2016/08/12
Target sample size: 4
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027186
Study type:  Interventional
Study design:  Single arm Non-randomized  
Phase:  Not selected
Countries of recruitment
Japan
Contacts
Name:     Hiroyuki Kitagawa
Address:  Kohasu-Okocho, Nankoku, Kochi 783-8505, Japan Japan
Telephone: 088-866-5811
Email: im31@kochi-u.ac.jp
Affiliation:  Kochi Medical School Department of Surgery, Kochi Medical School
Name:     Kazuhiro hanazaki
Address:  Department of Surgery, Kochi Medical School, Kohasu-Okocho, Nankoku, Kochi 783-8505, Japan Japan
Telephone: 088-866-5811
Email: im31@kochi-u.ac.jp
Affiliation:  Kochi Medical School Department of Surgery
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: (1) Allergy (2) Prticipate to other clinical trials within 16 weeks (3) Blood donation more than 400 ml within 12 weeks (4) Severe liver, heart or blood disease (5) Alchol and smooking (6) Drugs (7) Supllyments or diets which contains the ingredients of Maoto (8) Diagnosed as inappropriate by doctor (9) Positive HCV antibody, HBs antigen, and HIV antibody (10) Use of amphetamine and methamphetamine

Age minimum: 20years-old
Age maximum: 45years-old
Gender: Male
Health Condition(s) or Problem(s) studied
Healthy adult
Intervention(s)
Moat (TJ-27)
Primary Outcome(s)
Detect of ingredients delivers from Maoto in plasma.
Secondary Outcome(s)
Calculation of PK parameters and detect of ingredients delivers from Maoto in urine.
Secondary ID(s)
Source(s) of Monetary Support
Japan Agency for Medical Research and Development
Secondary Sponsor(s)
Tsumura & Co.
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history